Champions Oncology (CSBR) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to $268000.0.
- Champions Oncology's Profit After Tax fell 6318.68% to $268000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.5 million, marking a year-over-year increase of 51170.57%. This contributed to the annual value of $4.7 million for FY2025, which is 16460.97% up from last year.
- According to the latest figures from Q4 2025, Champions Oncology's Profit After Tax is $268000.0, which was down 6318.68% from -$466000.0 recorded in Q3 2025.
- In the past 5 years, Champions Oncology's Profit After Tax ranged from a high of $4.5 million in Q1 2025 and a low of -$2.6 million during Q3 2023
- Over the past 5 years, Champions Oncology's median Profit After Tax value was -$245500.0 (recorded in 2021), while the average stood at -$363700.0.
- As far as peak fluctuations go, Champions Oncology's Profit After Tax skyrocketed by 2760000.0% in 2021, and later tumbled by 1284375.0% in 2023.
- Quarter analysis of 5 years shows Champions Oncology's Profit After Tax stood at $277000.0 in 2021, then tumbled by 105.78% to -$16000.0 in 2022, then plummeted by 12843.75% to -$2.1 million in 2023, then skyrocketed by 135.15% to $728000.0 in 2024, then crashed by 63.19% to $268000.0 in 2025.
- Its Profit After Tax stands at $268000.0 for Q4 2025, versus -$466000.0 for Q3 2025 and -$1.8 million for Q2 2025.